Truist Financial’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-22,087
Closed -$226K 2699
2023
Q3
$226K Buy
22,087
+1,631
+8% +$20.1K ﹤0.01% 2396
2023
Q2
$282K Buy
20,456
+5,744
+39% +$86.2K ﹤0.01% 2282
2023
Q1
$239K Buy
14,712
+4,350
+42% +$81.9K ﹤0.01% 2339
2022
Q4
$183K Buy
+10,362
New +$206K ﹤0.01% 2425
2022
Q3
Sell
-13,912
Closed -$277K 2634
2022
Q2
$277K Sell
13,912
-2,752
-17% -$61.5K ﹤0.01% 2268
2022
Q1
$430K Sell
16,664
-2,563
-13% -$66.5K ﹤0.01% 2089
2021
Q4
$485K Sell
19,227
-14,423
-43% -$399K ﹤0.01% 2037
2021
Q3
$904K Buy
33,650
+1,879
+6% +$54.1K ﹤0.01% 1672
2021
Q2
$1.01M Buy
31,771
+15,390
+94% +$489K ﹤0.01% 1641
2021
Q1
$576K Buy
16,381
+4,659
+40% +$162K ﹤0.01% 1889
2020
Q4
$375K Buy
+11,722
New +$361K ﹤0.01% 2019
2020
Q1
Sell
-13,642
Closed -$321K 2535
2019
Q4
$321K Buy
+13,642
New +$306K ﹤0.01% 2109

Other funds holding PETS

Truist Financial's PETS Position: Q4 2023 in Review

Truist Financial sold out of PetMed Express (PETS) in Q4 2023, closing a stake of 22,087 shares — an estimated $226K sold.

Truist Financial first reported a position in PETS in Q4 2019 and held it in 12 quarters. The position peaked at $1.01M in Q2 2021. 130 funds tracked by Wall St. Rank hold PETS as of Q4 2023.

  • Truist Financial reported no remaining PetMed Express position as of Q4 2023 after selling out during the quarter.
  • Truist Financial sold 22,087 PetMed Express shares in Q4 2023, an estimated $226K.
  • Truist Financial first reported a position in PetMed Express in Q4 2019 and held it in 12 quarters.
  • Truist Financial's PetMed Express position peaked at $1.01M in Q2 2021.
  • 130 funds tracked by Wall St. Rank held PetMed Express as of Q4 2023.

Based on Truist Financial's 13F filing for Q4 2023, filed 2 Feb 2024.